Evidence-based supportive care in multiple myeloma.
Anum QureshiMuhammad Junaid TariqZunairah ShahMuhammad Abu ZarShehroz AslamAbdul RafaeMadeeha ShafqatMustafa Nadeem MalikMuhammad Salam FaisalFaiz AnwarPublished in: Journal of community hospital internal medicine perspectives (2020)
Multiple myeloma (MM) is a hematological malignancy characterized by an abnormal clone of plasma cells in the bone marrow. MM and its therapy increase the risk of complications like anemia, osteolytic lesions, pain, infections, and renal abnormalities in MM patients. Supportive care for MM patients improves the quality of life. Treatment with bisphosphonates decreases skeletal-related events. Vertebroplasty and kyphoplasty are done in cases of vertebral compression fractures. Prophylactic antibiotics and antivirals can decrease infections related to morbidity. Plasmapheresis in patients with renal dysfunctions decreases dialysis dependency and improve quality of life.
Keyphrases
- end stage renal disease
- chronic kidney disease
- multiple myeloma
- bone marrow
- ejection fraction
- peritoneal dialysis
- healthcare
- newly diagnosed
- induced apoptosis
- prognostic factors
- stem cells
- chronic pain
- pain management
- quality improvement
- spinal cord injury
- risk factors
- cell death
- patient reported outcomes
- patient reported